Cargando…

The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors

BACKGROUND: Inflammation is considered essential in cancer progression, as it affects the nutritional status and prognosis of patients. In this study, we aim to analyze the efficacy of various inflammatory markers in predicting prognosis in cancer patients. METHODS: Patients with malignant tumor wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Kaiwen, Liu, Xiangliang, Ji, Wei, Lu, Jin, Cui, Jiuwei, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573157/
https://www.ncbi.nlm.nih.gov/pubmed/34764670
http://dx.doi.org/10.2147/JIR.S334941
_version_ 1784595361922285568
author Zheng, Kaiwen
Liu, Xiangliang
Ji, Wei
Lu, Jin
Cui, Jiuwei
Li, Wei
author_facet Zheng, Kaiwen
Liu, Xiangliang
Ji, Wei
Lu, Jin
Cui, Jiuwei
Li, Wei
author_sort Zheng, Kaiwen
collection PubMed
description BACKGROUND: Inflammation is considered essential in cancer progression, as it affects the nutritional status and prognosis of patients. In this study, we aim to analyze the efficacy of various inflammatory markers in predicting prognosis in cancer patients. METHODS: Patients with malignant tumor were included as primary and validation cohort. Basic clinical information, anthropometric indicators, body composition analysis, and serological indicators were recorded. After proposing the optimal thresholds by time-dependent receiver operating characteristic (ROC), univariate and multivariate Cox regression analyses were performed to analyze the association between inflammatory markers and overall survival (OS). A nomogram was established to develop a scored-inflammatory marker system. Eight inflammatory models based on combinations of inflammatory markers were assessed. Cox regression analysis was used to analyze the relationship of each inflammatory model and mortality of participants. Then, subanalysis of specific tumor types was conducted by Cox regression. Logistic regression models were used to analyze the relationship between different inflammatory models and malnutrition. RESULTS: Univariate and multivariate Cox regression analyses indicated that pack-years of cigarette smoking, C-reactive protein (CRP), and systemic immune-inflammation index (SII) were related to the OS of cancer patients. A nomogram was constructed to develop a scored-inflammatory marker system. Among the eight inflammatory models, patients in model A had worst prognosis compared with patients in other models. Subanalysis next showed lung cancer, breast cancer and digestive system neoplasms patients in model A suffered the worst prognosis. Logistic regression indicated that model A was also with predictive value for malnutrition. CONCLUSION: A scored-inflammatory marker system was established to predict the OS of cancer patients. The inflammatory models established in this study can be used to predict prognosis, as well as cancer-related malnutrition. Inflammatory model A suffered the worst OS and was with the predictive efficacy for malnutrition.
format Online
Article
Text
id pubmed-8573157
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85731572021-11-10 The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors Zheng, Kaiwen Liu, Xiangliang Ji, Wei Lu, Jin Cui, Jiuwei Li, Wei J Inflamm Res Original Research BACKGROUND: Inflammation is considered essential in cancer progression, as it affects the nutritional status and prognosis of patients. In this study, we aim to analyze the efficacy of various inflammatory markers in predicting prognosis in cancer patients. METHODS: Patients with malignant tumor were included as primary and validation cohort. Basic clinical information, anthropometric indicators, body composition analysis, and serological indicators were recorded. After proposing the optimal thresholds by time-dependent receiver operating characteristic (ROC), univariate and multivariate Cox regression analyses were performed to analyze the association between inflammatory markers and overall survival (OS). A nomogram was established to develop a scored-inflammatory marker system. Eight inflammatory models based on combinations of inflammatory markers were assessed. Cox regression analysis was used to analyze the relationship of each inflammatory model and mortality of participants. Then, subanalysis of specific tumor types was conducted by Cox regression. Logistic regression models were used to analyze the relationship between different inflammatory models and malnutrition. RESULTS: Univariate and multivariate Cox regression analyses indicated that pack-years of cigarette smoking, C-reactive protein (CRP), and systemic immune-inflammation index (SII) were related to the OS of cancer patients. A nomogram was constructed to develop a scored-inflammatory marker system. Among the eight inflammatory models, patients in model A had worst prognosis compared with patients in other models. Subanalysis next showed lung cancer, breast cancer and digestive system neoplasms patients in model A suffered the worst prognosis. Logistic regression indicated that model A was also with predictive value for malnutrition. CONCLUSION: A scored-inflammatory marker system was established to predict the OS of cancer patients. The inflammatory models established in this study can be used to predict prognosis, as well as cancer-related malnutrition. Inflammatory model A suffered the worst OS and was with the predictive efficacy for malnutrition. Dove 2021-11-03 /pmc/articles/PMC8573157/ /pubmed/34764670 http://dx.doi.org/10.2147/JIR.S334941 Text en © 2021 Zheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zheng, Kaiwen
Liu, Xiangliang
Ji, Wei
Lu, Jin
Cui, Jiuwei
Li, Wei
The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
title The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
title_full The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
title_fullStr The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
title_full_unstemmed The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
title_short The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
title_sort efficacy of different inflammatory markers for the prognosis of patients with malignant tumors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573157/
https://www.ncbi.nlm.nih.gov/pubmed/34764670
http://dx.doi.org/10.2147/JIR.S334941
work_keys_str_mv AT zhengkaiwen theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT liuxiangliang theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT jiwei theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT lujin theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT cuijiuwei theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT liwei theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT zhengkaiwen efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT liuxiangliang efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT jiwei efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT lujin efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT cuijiuwei efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors
AT liwei efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors